Survey of Ophthalmology
Volume 48, Issue 3 , Pages 314-346 , May 2003

Antifibrotics and Wound Healing in Glaucoma Surgery

  • Paul J Lama, MD

      Affiliations

    • Corresponding Author InformationReprint address: Paul J. Lama, MD, Assistant Professor, Department of Ophthalmology, New Jersey Medical School, 90 Bergen Street, Suite 6100, Newark, NJ 07103
    • ,
  • Robert D Fechtner, MD

References 

  1. —: The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130:429–440
  2. —: Five-year follow-up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group. Am J Ophthalmol. 1996;121:349–366
  3. Akova YA, Koc F, Yalvac I, Duman S. Scleromalacia following trabeculectomy with intraoperative mitomycin C. Eur J Ophthalmol. 1999;9:63–65
  4. Anand N, Sahni K, Menage MJ. Modification of trabeculectomy with single-dose intraoperative 5-Fluorouracil application. Acta Ophthalmol Scand. 1998;76:83–89
  5. Araie M, Shoji N, Shirato S, Nakano Y. Postoperative subconjunctival 5-fluorouracil injections and success probability of trabeculectomy in Japanese: results of 5-year follow-up. Jpn J Ophthalmol. 1992;36:158–168
  6. Araujo SV, Spaeth GL, Roth SM, Starita RJ. A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology. 1995;102:1753–1759
  7. Azuara-Blanco A, Moster MR, Wilson RP, Schmidt CM. Simultaneous use of mitomycin-C with Baerveldt implantation. Ophthalmic Surg Lasers. 1997;28:992–997
  8. Azuara-Blanco A, Spaeth GL, Augsburger JJ. Oral prednisone in guarded filtration procedures supplemented with antimetabolites. Ophthalmic Surg Lasers. 1999;30:126–132
  9. Azuara-Blanco A, Wilson RP, Spaeth GL, et al.  Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma. Br J Ophthalmol. 1999;83:151–156
  10. Bell RW, Habib NE, O'Brien C. Long-term results and complications after trabeculectomy with a single per-operative application of 5-fluorouracil. Eye. 1997;11:663–671
  11. Blumenkranz M, Hernandez E, Ophir A, Norton EW. 5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology. 1984;91:122–130
  12. Brancato L, Yablonski M. Effect of dexamethasone and D-penicillamine in filtration surgery. [abstract] Invest Ophthalmol Vis Sci. 1983;24(Suppl):87
  13. Broadway D, Grierson I, Hitchings R. Adverse effects of topical antiglaucoma medications on the conjunctiva. Br J Ophthalmol. 1993;77:790–796
  14. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication (I. The conjunctival cell profile). Arch Ophthalmol. 1994;112:1437–1445
  15. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication (II. The outcome of filtration surgery). Arch Ophthalmol. 1994;112:1446–1454
  16. Broadway DC, Grierson I, Sturmer J, Hitchings RA. Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol. 1996;114:262–267
  17. Budenz DL, Pyfer M, Singh K, et al.  Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents. Ophthalmic Surg Lasers. 1999;30:367–374
  18. Cantor L, Burgoyne J, Sanders S, et al.  The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study. J Glaucoma. 1998;7:240–246
  19. Carlson DW, Alward WL, Barad JP, et al.  A randomized study of mitomycin augmentation in combined phacoemul-sification and trabeculectomy. Ophthalmology. 1997;104:719–724
  20. Caronia RM, Liebmann JM, Friedman R, et al.  Trabeculectomy at the inferior limbus. Arch Ophthalmol. 1996;114:387–391
  21. Cashwell LF, Shields MB. Surgical management of coexisting cataract and glaucoma. In:  Ritch R,  Krupin T,  Shields MB editor. ed 2. The Glaucomas. Vol III:St. Louis: Mosby; 1996;p. 1745–1760
  22. Chaudhry IA, Pasha MA, OConnor DJ, et al.  Randomized, controlled study of low-dose 5-fluorouracil in primary trabeculectomy. Am J Ophthalmol. 2000;130:700–703
  23. Chen CW, Huang HT, Sheu MM. Enhancement of IOP control effect of trabeculectomy by local application of anticancer drug. Acta Ophthalmol Scand. 1986;25:1487–1491
  24. Cheung JC, Wright MM, Murali S, Pederson JE. Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology. 1997;104:143–149
  25. Cohen JS, Greff LJ, Novack GD, Wind BE. A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Ophthalmology. 1996;103:1934–1942
  26. Connor TB, Roberts AB, Sporn MB: Correlation of fibrosis and transforming growth factor-b type 2 levels in the eye. J Clin Invest. 83:1661–6, 19
  27. Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci. 1999;40:2225–2234
  28. Cunliffe IA, Longstaff S. Intraoperative use of 5-fluorouracil in glaucoma filtering surgery. Acta Ophthalmol (Copenh). 1993;71:739–743
  29. Daniels JT, Occleston NL, Crowston JG, Khaw PT. Effects of antimetabolite induced cellular growth arrest on fibroblast–fibroblast interactions. Exp Eye Res. 1999;69:117–127
  30. Dellaporta A. Fundus changes in postoperative hypotony. Am J Ophthalmology. 1955;40:781–785
  31. Demailly P, Kretz G. Daunorubicin versus 5-fluoro-uracil in surgical treatment of primary open angle glaucoma: a prospective study. Int Ophthalmol. 1992;16:367–370
  32. Dietze PJ, Feldman RM, Gross RL. Intraoperative application of 5-fluorouracil during trabeculectomy. Ophthalmic Surg. 1992;23:662–665
  33. Donoso R, Rodriguez A. Combined versus sequential phacotrabeculectomy with intraoperative 5-fluorouracil. J Cataract Refract Surg. 2000;26:71–74
  34. Entzian P, Schlaak M, Seitzer U, et al.  Antiinflammatory and antifibrotic properties of colchicine: implications for idiopathic pulmonary fibrosis. Lung. 1997;175:41–51
  35. Falck FY, Skuta GL, Klein TB. Mitomycin versus 5-Fluorouracil antimetabolite therapy for glaucoma filtration surgery. Semin Ophthalmol. 1992;7:97
  36. Fourman S. Scleritis after glaucoma filtering surgery with mitomycin C. Ophthalmology. 1995;102:1569–1571
  37. Freedman SF, McCormick K, Cox TA. Mitomycin C-augumented trabeculectomy with postoperative wound modulation in pediatric glaucoma. J AAPOS. 1999;3:117–124
  38. Gandolfi SA, Vecchi M. 5-fluorouracil in combined trabeculectomy and clear-cornea phacoemulsification with posterior chamber intraocular lens implantation. A one-year randomized, controlled clinical trial. Ophthalmology. 1997;104:181–186
  39. Gass JDM. Hypotony maculopathy. In:  Bellows JG editors. Contemporary Ophthalmology. Baltimore: Williams and Wilkins; 1972; chap 34
  40. Goldenfeld M, Krupin T, Ruderman JM, et al.  5-Fluorouracil in initial trabeculectomy. A prospective, randomized, multicenter study. Ophthalmology. 1994;101:1024–1029
  41. Greenfield DS, Liebmann JM, Jee J, Ritch R. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol. 1998;116:443–447
  42. Greenfield DS, Suner IJ, Miller MP, et al.  Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol. 1996;114:943–949
  43. Gressel MG, Parrish RK, Folberg R. 5-fluorouracil and glaucoma filtering surgery (I. An animal model). Ophthalmology. 1984;91:378–383
  44. Hennis HL, Stewart WC. The use of 5-fluorouracil in patients following combined trabeculectomy and cataract extraction. Ophthalmic Surg. 1991;22:451–454
  45. Heuer DK, Parrish RK, Gressel MG, et al.  5-Fluorouracil and glaucoma filtering surgery (III. Intermediate follow- up of a pilot study). Ophthalmology. 1986;93:1537–1546
  46. Higginbotham EJ, Stevens RK, Musch DC, et al.  Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology. 1996;103:650–656
  47. Jacobi PC, Dietlein TS, Krieglstein GK. Adjunctive mitomycin C in primary trabeculectomy in young adults: a long-term study of case-matched young patients. Graefes Arch Clin Exp Ophthalmol. 1998;236:652–657
  48. Jampel HD. Ascorbic acid is cytotoxic to dividing human Tenons capsule fibroblasts. A possible contributing factor in glaucoma filtration surgery success. Arch Ophthalmol. 1990;108:1323–1325
  49. Jampel HD, Jabs DA, Quigley HA. Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol. 1990;109:168–173
  50. Jampel HD, Leong KW, Dunkelburger GR, Quigley HA. Glaucoma filtration surgery in monkeys using 5-fluorouridine in polyanhydride disks. Arch Ophthalmol. 1990;108:430–435
  51. Jampel HD, Moon JI, Quigley HA, et al.  Aqueous humor uric acid and ascorbic acid concentrations and outcome of trabeculectomy. Arch Ophthalmol. 1998;116:281–285
  52. Jampel HD, Quigley HA, Kerrigan-Baumrind LA, et al.  Risk factors for late-onset infection following glaucoma filtration surgery. Arch Ophthalmol. 2001;119:1001–1008
  53. Karalekas D, Hyderi A, Rosenberg L. Effects of human glaucomatous and non-glaucomatous aqueous humor on fibroblast proliferation in vitro. [abstract] Invest Ophthalmol Vis Sci. 1994;35(Suppl):198
  54. Katz GJ, Higginbotham EJ, Lichter PR, et al.  Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. Ophthalmology. 1995;102:1263–1269
  55. Kent AR, Dubiner HB, Whitaker R, et al.  The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C. Ophthalmic Surg Lasers. 1998;29:562–569
  56. Kershenobich D, Vargas F, Garcia-Tsao G, et al.  Colchicine in the treatment of cirrhosis of the liver. N Engl J Med. 1988;318:1709–1713
  57. Khaw PT, Doyle JW, Sherwood MB, et al.  Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin. Arch Ophthalmol. 1993;111:263–267
  58. Khaw PT, Occleston NL, Larkin G. The effects of growth factors on human ocular fibroblast proliferation, migration, and collagen production. [abstract] Invest Ophthalmol Vis Sci. 1994;35:1898
  59. Khaw PT, Sherwood MB, Doyle JW, et al.  Intraoperative and post operative treatment with 5-fluorouracil and mitomycin-C: long term effects in vivo on subconjunctival and scleral fibroblasts. Int Ophthalmol. 1992;16:381–385
  60. Khaw PT, Sherwood MB, Mackay SLD. Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts. Arch Ophthalmol. 1992;110:1150–1154
  61. Knapp A, Heuer DK, Stern GA, Driebe WT. Serious corneal complications of glaucoma filtering surgery with postoperative 5-fluorouracil. Am J Ophthalmol. 1987;103:183–187
  62. Lamping KA, Belkin JK. 5-Fluorouracil and mitomycin C in pseudophakic patients. Ophthalmology. 1995;102:70–75
  63. Lamping KA, Belkin JK. 5-Fluorouracil and mitomycin C in pseudophakic patients. Ophthalmology. 1995;102:70–75
  64. Lanigan L, Sturmer J, Baez KA, et al.  Single intraoperative applications of 5-fluorouracil during filtration surgery: early results. Br J Ophthalmol. 1994;78:33–37
  65. Lee D, Shin DH, Birt CM, et al.  The effect of adjunctive mitomycin C in Molteno implant surgery. Ophthalmology. 1997;104:2126–2135
  66. Lee DA, Flores RA, Anderson PJ, et al.  Glaucoma filtration surgery in rabbits using bioerodible polymers and 5-fluorouracil. Ophthalmology. 1987;94:1523–1530
  67. Lichter PR, Musch DC, Gillespie BW, et al.  Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953
  68. Liebmann JM, Ritch R, Marmor M, et al.  Initial 5-fluorouracil trabeculectomy in uncomplicated glaucoma. Ophthalmology. 1991;98:1036–1041
  69. Logan A, Green J, Hunter A. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-b2. Eur J Neurosci. 1999;11:2367–2374
  70. Mandal AK, Prasad K, Naduvilath TJ. Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma. Ophthalmic Surg Lasers. 1999;30:473–480
  71. Matsuda T, Tanihara H, Hangai M, et al.  Surgical results and complications of trabeculectomy with intraoperative application of mitomycin C. Jpn J Ophthalmol. 1996;40:526–532
  72. McGuigan LJ, Mason RP, Sanchez R, Quigley HA. D-penicillamine and beta-aminopropionitrile effects on experimental filtering surgery. Invest Ophthalmol Vis Sci. 1987;28:1625–1629
  73. McGuigan LJ, Quigley HA, Lutty G, et al.  The effects of D-penicillamine and daunorubicin on conjunctival fibroblast proliferation and collagen synthesis. Invest Ophthalmol Vis Sci. 1988;29:112–118
  74. Moorhead LC. Effects of topically administered beta aminoproprionitrile after glaucoma filtration surgery. [abstract] Invest Ophthalmol Vis Sci. 1984;25(Suppl):44
  75. Mora JS, Nguyen N, Iwach AG, et al.  Trabeculectomy with intraoperative sponge 5-fluorouracil. Ophthalmology. 1996;103:963–970
  76. Nimni ME. Collagen: structure, function, and metabolism in normal and fibrotic tissues. Semin Arthritis Rheum. 1983;13:1–86
  77. O'Grady JM, Juzych MS, Shin DH, et al.  Trabeculectomy, phacoemulsification, and posterior chamber lens implantation with and without 5-fluorouracil. Am J Ophthalmol. 1993;116:594–599
  78. Occleston NL, Alexander RA, Mazure A, et al.  Effects of single exposures to antiproliferative agents on ocular fibroblast-mediated collagen contraction. Invest Ophthalmol Vis Sci. 1994;35:3681–3690
  79. Oh SY, Youn DH, Kim DM, Hong C. The effects of intraoperative mitomycin-C or 5-fluorouracil on glaucoma filtering surgery. Korean J Ophthalmol. 1994;8:6–13
  80. Ophir A, Ticho U. A randomized study of trabeculectomy and subconjunctival administration of fluorouracil in primary glaucomas. Arch Ophthalmol. 1992;110:1072–1075
  81. Orengo-Nania S, Verdugo M, Pineyro A. TGF-b2 concentration in the aqueous humor of patients with glaucoma and cataract. [abstract] Invest Ophthalmol Vis Sci. 1996;37(Suppl):27
  82. Patitsas CJ, Rockwood EJ, Meisler DM, Lowder CY. Glaucoma filtering surgery with postoperative 5-fluorouracil in patients with intraocular inflammatory disease. Ophthalmology. 1992;99:594–599
  83. Perkins TW, Gangnon R, Ladd W, et al.  Trabeculectomy with mitomycin C: intermediate-term results. J Glaucoma. 1998;7:230–236
  84. Perkins TW, Gangnon R, Ladd W, et al.  Molteno implant with mitomycin C: intermediate-term results. J Glaucoma. 1998;7:86–92
  85. Prata JA, Minckler DS, Baerveldt G, et al.  Trabeculectomy in pseudophakic patients: postoperative 5-fluorouracil versus intraoperative mitomycin C antiproliferative therapy. Ophthalmic Surg. 1995;26:73–77
  86. Ren J, Shin DH, OGrady JM, et al.  Long-term outcome of primary glaucoma triple procedure with adjunctive 5-fluorouracil. Graefes Arch Clin Exp Ophthalmol. 1998;236:501–506
  87. Robbins SL, Cotran RS, Kumar V. Pathologic Basis of Disease. ed 3. New York: WB Saunders Company; 1984;
  88. Rockwood EJ, Parrish RK, Heuer DK, et al.  Glaucoma filtering surgery with 5-fluorouracil. Ophthalmology. 1987;94:1071–1078
  89. Roth SM, Spaeth GL, Starita RJ, et al.  The effects of postoperative corticosteroids on trabeculectomy and the clinical course of glaucoma: five-year follow-up study. Ophthalmic Surg. 1991;22:724–729
  90. Rothman RF, Liebmann JM, Ritch R. Low-dose 5-fluorouracil trabeculectomy as initial surgery in uncomplicated glaucoma: long-term followup. Ophthalmology. 2000;107:1184–1190
  91. Rubinfeld RS, Pfister RR, Stein RM, et al.  Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99:1647–1654
  92. Ruderman JM, Welch DB, Smith MF, Shoch DE. A randomized study of 5-fluorouracil and filtration surgery. Am J Ophthalmol. 1987;104:218–224
  93. Sakamoto T, Oshima Y, Sakamoto M, et al.  Electroporation and bleomycin in glaucoma-filtering surgery. Invest Ophthalmol Vis Sci. 1997;38:2864–2868
  94. Salas-Prato M, Assalian A, Mehdi AZ. Rapamycin inhibition of PDGF- and bFGF-induced in vitro proliferation of human Tenons capsule fibroblasts. [abstract] Invest Ophthalmol Vis Sci. 1994;35(Suppl):1898
  95. Salmon SE, Sartorelli AC. Cancer chemotherapy. In:  Katsung BG editors. Basic and Clinical Pharmacology. ed 3. Norwalk, CT: Appleton and Lange; 1987;p. 676
  96. Salmon SE, Sartorelli AC. Cancer chemotherapy. In:  Katsung BG editors. Basic and Clinical Pharmacology. ed 3. Norwalk, CT: Appleton and Lange; 1987;p. 680–681
  97. Shapiro MS, Thoft RA, Friend J, et al.  5-Fluorouracil toxicity to the ocular surface epithelium. Invest Ophthalmol Vis Sci. 1985;26:580–583
  98. Shearn MA. Basic and clinical pharmacology. ed 3. Norwalk, CT: Appleton and Lange; 1987;
  99. Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenons capsule in glaucomatous patients. Ophthalmology. 1989;96:327–335
  100. Shin DH, Ren J, Juzych MS, et al.  Primary glaucoma triple procedure in patients with primary open-angle glaucoma: the effect of mitomycin C in patients with and without prognostic factors for filtration failure. Am J Ophthalmol. 1998;125:346–352
  101. Sidoti PA, Belmonte SJ, Liebmann JM, Ritch R. Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology. 2000;107:422–429
  102. Sidoti PA, Choi JC, Morinelli EN, et al.  Trabeculectomy with intraoperative 5-fluorouracil. Ophthalmic Surg Lasers. 1998;29:552–561
  103. Sihota R, Sharma T, Agarwal HC. Intraoperative mitomycin C and the corneal endothelium. Acta Ophthalmol Scand. 1998;76:80–82
  104. Simmons RJ. Filtering operations Chandler and Grants Glaucoma. ed 3. Philadelphia: Lea and Febiger; 1986; pp 420–50
  105. Singh J, OBrien C, Chawla HB. Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. Eye. 1995;9:460–466
  106. Singh K, Mehta K, Shaikh NM, et al.  Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology. 2000;107:2305–2309
  107. Smith MF, Doyle JW, Nguyen QH, Sherwood MB. Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery. J Glaucoma. 1997;6:104–110
  108. Smith MF, Sherwood MB, Doyle JW, Khaw PT. Results of intraoperative 5-fluorouracil supplementation on trabeculectomy for open-angle glaucoma. Am J Ophthalmol. 1992;114:737–741
  109. Smith S, DAmore PA, Dreyer EB. Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol. 1994;118:332–337
  110. Soltau JB, Rothman RF, Budenz DL, et al.  Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol. 2000;118:338–342
  111. Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J Ophthalmol. 1992;114:544–553
  112. Starita RJ, Fellman RL, Spaeth GL, et al.  Short- and long-term effects of postoperative corticosteroids on trabeculectomy. Ophthalmology. 1985;92:938–946
  113. Suner IJ, Greenfield DS, Miller MP, et al.  Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. Ophthalmology. 1997;104:207–214 discussion 214–5
  114. Towler HM, McCluskey P, Shaer B, Lightman S. Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology. 2000;107:1822–1828
  115. Traverso CE, Facino M, Murialdo U, et al.  Decreased corneal complications after no-reflux, low-dose 5 fluorouracil subconjunctival injection following trabeculectomy. Int Ophthalmol. 1994;18:247–250
  116. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res. 1994;59:723–727
  117. Tsai JC, Feuer WJ, Parrish RK, Grajewski AL. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology. 1995;102:887–892 discussion 892–3
  118. Volcker HE, Naumannn GOH. Morphology of uveal and retinal edema in acute and persisting hypotony. Mod Probl Ophthalmol. 1979;20:33
  119. Warnes TW. Colchicine in primary biliary cirrhosis. Aliment Pharmacol Ther. 1991;5:321–329
  120. Watts P, Karia N, McAllister J. Is the single use of intraoperative 5-fluorouracil in filtering surgery for high-risk cases enough?. Eye. 1998;12:374–378
  121. Weinreb RN. Riding the Trojan horse of glaucoma surgery. J Glaucoma. 1995;4:2–4
  122. Weinreb RN. Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology. 1987;94:564–570
  123. Whiteside-Michel J, Liebmann JM, Ritch R. Initial 5-fluorouracil trabeculectomy in young patients. Ophthalmology. 1992;99:7–13
  124. Whitson JT, Li L, Park SS. Elevated TGF-beta levels in aqueous humor of human eyes with failed filtration bleb. [abstract] Invest Ophthalmol Vis Sci. 1996;37(Suppl):27
  125. Wilson RP, Steinmann WC. Use of trabeculectomy with postoperative 5-fluorouracil in patients requiring extremely low intraocular pressure levels to limit further glaucoma progression. Ophthalmology. 1991;98:1047–1052
  126. Wolner B, Liebmann JM, Sassani JW, et al.  Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology. 1991;98:1053–1060
  127. Yalvac IS, Nurozler A, Kahraman C, et al.  The results of trabeculectomy with and without mitomycin C in young patients. Ophthalmologica. 1998;212:399–403
  128. Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol. 1993;116:314–326
  129. Zalish M, Leiba H, Oliver M. Subconjunctival injection of 5-fluorouracil following trabeculectomy for congenital and infantile glaucoma. Ophthalmic Surg. 1992;23:203–205

☆ Supported in part by unrestricted grants from Research to Prevent Blindness and The Glaucoma Research and Education Foundation. The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(03)00038-9

doi: 10.1016/S0039-6257(03)00038-9

Survey of Ophthalmology
Volume 48, Issue 3 , Pages 314-346 , May 2003

Article Tools

* Image Usage & Resolution